These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12715768)

  • 21. New office and new leader aim to streamline FDA cancer drug review process.
    Twombly R
    J Natl Cancer Inst; 2005 May; 97(10):708-9. PubMed ID: 15900036
    [No Abstract]   [Full Text] [Related]  

  • 22. The Center for Devices and Radiological health: an update.
    Donawa M
    Med Device Technol; 2001 Dec; 12(10):24, 26-7. PubMed ID: 15966141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Science, ethics and economics in FDA decision-making: the legal framework.
    Cooper RM
    Food Drug Law J; 2006; 61(4):799-803. PubMed ID: 17180773
    [No Abstract]   [Full Text] [Related]  

  • 24. Many issues in store for new FDA commissioner.
    Wadman M
    Nat Rev Drug Discov; 2005 Nov; 4(11):871-2. PubMed ID: 16299912
    [No Abstract]   [Full Text] [Related]  

  • 25. Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.
    Wang Y; Bhattaram AV; Jadhav PR; Lesko LJ; Madabushi R; Powell JR; Qiu W; Sun H; Yim DS; Zheng JJ; Gobburu JV
    J Clin Pharmacol; 2008 Feb; 48(2):146-56. PubMed ID: 18199891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving women's health through modernization of our bioinformatics infrastructure.
    Oliva A; Pinnow E; Levin R; Uhl K
    Clin Pharmacol Ther; 2008 Jan; 83(1):192-5. PubMed ID: 17987048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. State of the FDA.
    von Eschenbach AC
    Food Drug Law J; 2007; 62(2):423-7. PubMed ID: 17632970
    [No Abstract]   [Full Text] [Related]  

  • 29. Remarks of the acting FDA commissioner: FDLI's 47th annual conference.
    Crawford LM
    Food Drug Law J; 2004; 59(2):201-8. PubMed ID: 15318391
    [No Abstract]   [Full Text] [Related]  

  • 30. Janet Woodcock discusses the FDA and the drug development process. Interview by Christopher Watson.
    Woodcock J
    Drug Discov Today; 2004 Jul; 9(13):548-50. PubMed ID: 15203087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vision and will: the future of the FDA.
    Epstein D
    Oncologist; 2009 Apr; 14(4):317-9. PubMed ID: 19365098
    [No Abstract]   [Full Text] [Related]  

  • 32. Newsmaker interview. Margaret Hamburg aims to strengthen FDA science. Interview by Robert Koenig.
    Hamburg M
    Science; 2009 Aug; 325(5942):802. PubMed ID: 19679780
    [No Abstract]   [Full Text] [Related]  

  • 33. Protecting FDA's ability to protect public health.
    Taylor MR
    Food Drug Law J; 2006; 61(4):805-8. PubMed ID: 17180774
    [No Abstract]   [Full Text] [Related]  

  • 34. More FDA resources to counter terrorism.
    FDA Consum; 2002; 36(3):4. PubMed ID: 12085814
    [No Abstract]   [Full Text] [Related]  

  • 35. How are drugs approved? Part 3. The stages of drug development.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2008 Mar; 46(3):17-20. PubMed ID: 18416270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leavitt: reforms will improve oversight and openness at FDA.
    FDA Consum; 2005; 39(3):37. PubMed ID: 16127819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDA and EMEA pool scientific advice.
    Katsnelson A
    Nat Biotechnol; 2004 Dec; 22(12):1490-1. PubMed ID: 15583642
    [No Abstract]   [Full Text] [Related]  

  • 38. Food from cloned animals is part of our brave old world.
    Miller HI
    Trends Biotechnol; 2007 May; 25(5):201-3. PubMed ID: 17374411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A turbulent year at the agency.
    Ratner M
    Nat Biotechnol; 2006 Feb; 24(2):145-51. PubMed ID: 16465153
    [No Abstract]   [Full Text] [Related]  

  • 40. Remarks at FDLI's 46th annual educational conference.
    Waxman HA
    Food Drug Law J; 2003; 58(2):205-9. PubMed ID: 12866553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.